Following an initial announcement of a subscription investment agreement deal from NAC last Tuesday (October 23), the company closed the first round of financing.
VIVO Cannabis was the first licensed producer to confirm its initial C$5 million investment with a possible extra C$5 million if NAC meets marked quotas attached to its retail plan last week.
Zenabis disclosed it signed up for up to C$15 million common shares of NAC with an initial C$5 million purchased during the first tranche, which closed last Friday (October 26).
Rick Brar, CEO of Zenabis, said his company sees this investment as a way to develop a relationship with a company looking to set up the “most widespread” retail network in Canada.
Zenabis is set to become a public producer by way of a reverse-takeover with Bevo Agro (TSXV:BVO) performed through Sun Pharm Investments.
The first tranche NAC announced provided the company with gross proceeds of C$20 million.
Mark Goliger, CEO of NAC, indicated the company expects to set up a footprint of over 200 cannabis retail shops in the next 18 months across five Canadian provinces.
In a statement to the Investing News Network (INN) Peter Aceto, CEO of CannTrust said NAC is “poised to transform the cannabis retail landscape.” Aceto added CannTrust will make available product the company’s adult-use brands to the eventual stores.
Details of investment transaction
The producers acquired stock of NAC at a price of C$0.91 per share. The total number of shares from the retail operator as part of the first tranche was approximately 22 million.
The second and third tranches of the investment deal are attached to specific goals: reaching 50 and 100 store approvals in Canada respectively.
The second and third tranches will close on October 26 in 2019 and 2020. However, NAC holds an option with all these producers to request the purchase of the subscribed stock agreed before the deadlines of the second and third tranches.
Adult-use cannabis became legal in Canada on October 17, allowing for the setup of physical retail shops, as per each province’s guidelines.
“We believe that the retail side of the industry has great potential and with our strong cash position, we chose to make another strategic investment in a leading cannabis retailer,” stated Barry Fishman, CEO of VIVO Cannabis.
NAC attracted attention to its retail play thanks to a deal with coffee retailer Second Cup (TSX:SCU) for a network of cannabis shops in Ontario.
Second Cup has even announced plans to retrofit existing coffee retail locations in favour of cannabis stores.
Shares of all the public cannabis producers in this deal took a sharp decline during Monday’s trading session.
At market closure on Monday,NAC shares dropped 1.23 percent reaching a price point of C$0.80. Aphria, CannTrust and VIVO took declines of 17.35, 15.43 and 8.57 percent on Monday.
Outside of a negative reaction to the investment deal, shares of cannabis companies have been taking a beating following Canadian legalization in what is seen as a sell off from investors.
Don’t forget to follow us @INN_Cannabis for real-time news updates!
Editor’s Note: This story was updated to include a statement from CannTrust. This story was updated to correct the name of Rick Brar, CEO of Zenabis.
Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.
American cannabis sales hit US$17.5 billion in 2020, a research group’s new study shows.
Meanwhile, a Canadian cannabis producer began offering CBD beverages in the US, another move that shows how interested Canadians are in the overall US cannabis market at the moment.
Some pretty important news out of health and wellness; beverage and natural products company BevCanna Enterprises Inc. (CSE:BEV, Q:BVNNF, FSE:7BC) this week. For those of you following the Company with us, stay tuned.
As investors continue to prioritize cannabis opportunities in the US, market watchers expect mergers and acquisitions (M&A) to play a role in the future for Canadian companies.
A consolidation trend has been expected in the Canadian cannabis space for some time now based on the size of the market compared to the number of operations in the country.
BioHarvest Sciences Inc. Unveils the Unique Polyphenolic Content of Its Upcoming Olive-Based Nutraceutical
The product will include polyphenols known to have significant health benefits.
BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”) has reached an important milestone in its development program of additional Nutraceuticals. The olive-based Nutraceutical product scheduled for market availability in the second half of 2022 will contain the following unique matrix of polyphenols: hydroxytyrosol, trosol, and verbascoside. These compounds are the major polyphenols in naturally grown olives and are responsible for the high antioxidant activity of olives and olive oil. Importantly, the BioHarvest olive-based Nutraceutical product will provide all the benefits of olives and olive oil with a low calorie count per serving.
Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today that it will report financial results for the fourth quarter and full year ended December 31 st , 2020 on Thursday March 25 th , 2021 before the market opens.
The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights on Thursday March 25 th , 2021 at 8:30am Eastern Time (7:30am Central Time).